NCT05391906Active, not recruiting
Intravoxel Incoherent Motion (IVIM) Magnetic Resonance Imaging in Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
Intravoxel incoherent motion (IVIM) is technique based on diffusion-weighted imaging (DWI). In this study, the investigators evaluate the use of IVIM in patients with Multiple Sclerosis.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 3 May 2022
- Start date
- 30 Jan 2023
- Primary completion date
- 20 Dec 2026
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Multiple sclerosis
- NCT number
- NCT05391906
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 30 Jan 2023 to the primary completion date, 20 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who are unable to tolerate the scans without moving the head as a result of symptoms such as tremor, spasticity, involuntary movements and spasms, cognitive impairment, coughing, and shortness of breath.
Other
- Contraindication to MRI. For example, metal implantation in the body, claustrophobia and pregnancy.
Who the study is looking for
- Patients who are 18 years or older.
- Relapsing-remitting MS diagnosed as per Macdonald criteria
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CUHK Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.